Your browser doesn't support javascript.
loading
Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial.
Gold, Kathryn A; Kies, Merrill S; William, William N; Johnson, Faye M; Lee, J Jack; Glisson, Bonnie S.
Affiliation
  • Gold KA; Division of Hematology and Oncology, Moores Cancer Center, University of California-San Diego, La Jolla, California.
  • Kies MS; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • William WN; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Johnson FM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Glisson BS; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer ; 124(10): 2169-2173, 2018 05 15.
Article in En | MEDLINE | ID: mdl-29579331
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell / Protein Kinase Inhibitors / Erlotinib Hydrochloride / Neoplasm Recurrence, Local Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell / Protein Kinase Inhibitors / Erlotinib Hydrochloride / Neoplasm Recurrence, Local Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2018 Type: Article